Clinical Trials Directory

Trials / Sponsors / Jianfeng Xie

Jianfeng Xie

Academic / Other · 13 registered clinical trials2 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingNafamostat Mesylate Versus Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy in Sepsis
Sepsis, Acute Kidney Injury, Continuous Renal Replacement Therapy (CRRT)
Phase 42026-04-01
CompletedInfluenza A-associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit in China
ICU, Invasive Pulmonary Aspergillosis, Influenza A
2025-11-01
RecruitingEpidemiological Investigation of Central Venous Catheter-related Bloodstream Infections in Icus in China
CLABSI - Central Line Associated Bloodstream Infection
2025-06-08
UnknownThe Effect and Mechanism of lncRNA NBR2 Regulating Endothelial Pyroptosis by Targeting GSDMD in Sepsis
Sepsis
2020-05-22
UnknownShenfu Injection Improves Arterial Vascular Reactivity
Septic Shock, Shenfu, Vascular Reactivity
Phase 2 / Phase 32018-12-01
UnknownEffects of Different Driving Pressure on Lung Stress, Strain and Mechanical Power in Patients With Moderate to
ARDS, Driving Pressure, Strains
2017-12-01
CompletedLong-term Quality of Life Among Survivors of Sepsis in China Assessed by EQ-5D
Sepsis
2015-11-01
CompletedEpidemiology of Sepsis in China
Sepsis
2015-11-01
CompletedDynamic Alterations of Th2/Th1 With New Onset of Community-acquired Severe Sepsis Patients
Sepsis
2014-09-01
CompletedARDS Prediction Score in Critically Ill Patients in China
ARDS, Septic Shock
2014-03-01
UnknownThe Classification of Difficult Weaning and the Predictive Value of Relative Factors for Difficult Weaning
Intensive Care Medicine, Mechanical Ventilation, Weaning
2012-06-01
CompletedAntimicrobial Stewardship Reduces MDRO Isolates in Critically Ill Patients
Sepsis
2012-06-01
UnknownDiagnostic and Prognostic Value of Combination Biomarkers in the Critically Ill Patient With Sepsis.
Diagnostic and Predictive Value
2012-03-01